Inactive Instrument

Merus Labs International Inc Share Price

Equities

Duration

Period

Style

28/02/17

Merus Labs International : Norgine B.V. completes acquisition of Merus Labs International Inc. strengthening its leading position in the European specialist pharma market	17/07/17	PR
Merus Labs International : Receives Court Approval in Connection with Proposed Plan of Arrangement with Norgine B.V.	13/07/17	PR
Merus Labs International : Shareholders Approve Plan of Arrangement with Norgine B.V.	10/07/17	PR
Merus Labs International : and Norgine B.V. receive Spanish anti-trust approval of proposed Arrangement of Fiscal Q1 2017 Earnings Release	04/07/17	PU
Merus Labs International : and Norgine B.V. receive Spanish anti-trust approval of proposed Arrangement	04/07/17	PR

Sector

	1st Jan change	Capi.
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.27%	43.18B
OTSUKA HOLDINGS CO., LTD.	+24.05%	23.23B
SANDOZ GROUP AG	+15.11%	14.6B
ZYDUS LIFESCIENCES LIMITED	+38.36%	11.5B
ONO PHARMACEUTICAL CO., LTD.	-7.63%	6.79B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+10.21%	5.31B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-2.27%	4.81B